Schonfeld Strategic Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,425
| Closed | -$830K | – | 2204 |
|
|
2025
Q1 | $830K | Buy |
18,425
+1,225
| +7% | +$55.2K | 0.01% | 1248 |
|
|
2024
Q4 | $711K | Buy |
17,200
+487
| +3% | +$20.1K | ﹤0.01% | 1205 |
|
|
2024
Q3 | $652K | Sell |
16,713
-5,531
| -25% | -$216K | ﹤0.01% | 1185 |
|
|
2024
Q2 | $761K | Buy |
+22,244
| New | +$761K | ﹤0.01% | 1197 |
|
|
2023
Q4 | – | Sell |
-21,799
| Closed | -$689K | – | 1940 |
|
|
2023
Q3 | $689K | Sell |
21,799
-15,966
| -42% | -$505K | 0.01% | 1008 |
|
|
2023
Q2 | $977K | Sell |
37,765
-57,660
| -60% | -$1.49M | 0.01% | 970 |
|
|
2023
Q1 | $2.29M | Buy |
95,425
+45,623
| +92% | +$1.1M | 0.02% | 650 |
|
|
2022
Q4 | $971K | Buy |
49,802
+5,262
| +12% | +$103K | 0.01% | 1159 |
|
|
2022
Q3 | $936K | Buy |
+44,540
| New | +$936K | 0.01% | 1299 |
|